Takeda, Janssen will co-market cancer drug Velcade in Japan

05/11/2010 | Mass High Tech (Boston)

Janssen Pharmaceutical agreed to co-promote cancer drug Velcade, by Millennium: The Takeda Oncology Co., with Takeda Pharmaceutical in a deal that will enable the latter to recover sales of the drug in Japan. "This collaboration will help maximize the potential of Velcade in a critically important market," Millennium CEO Deborah Dunsire said.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT